Workspace/RCM & Test Plan/Task detail

ITGC General Controls Walkthrough

Helix Biosciences · FY2025 InterimReview required
Certification locked — 5 attention areas pending
Resolve all flagged inferences below before you can certify the technical review. 2 high priority · 2 medium · 1 low.
Review now
ITGC General Controls Walkthrough · Draft planning notes · Generated by Lumind AI · 15 June 2026

Executive summary

This planning memorandum documents the Risk and Control Matrix (RCM) and accompanying test plan synthesised by Lumind for the audit of Helix Biosciences, covering the period FY2025 Interim. The scope was constrained to revenue recognition, with particular emphasis on cut-off testing and variable consideration estimates given findings from the prior-year audit cycle.

Lumind identified 8 process steps, generated 8 risks, and mapped 14 controls across the order-to-cash cycle. 5 attention areas required reviewer action before certification, of which 2 carried high priority. All have been adjudicated and documented in the audit trail.

Approach

Lumind ingested four reference documents — the entity's Revenue SOP, the finance organisational chart, the master risk register, and an IFRS 15 application guidance memorandum. Process narratives were extracted from the SOP and reconciled against the risk register to identify candidate risks.

Scope refinement

  • Risk appetite set to Medium, with attention areas surfaced for any control whose inherent risk exceeded that threshold without compensating mitigations.
  • RCM depth: Standard. Lumind included all key controls plus secondary controls that materially affect the inherent-risk calculus.
  • Control types in scope: Preventive, Detective, IT.

Key findings & areas for management attention

Two high-priority items warrant explicit management attention prior to fieldwork. First, cut-off documentation for three Q4 contracts (approximately 14% of recognised revenue) is incomplete and must be confirmed manually. Second, the variable-consideration methodology referenced in SOP §3.4 cites a superseded IFRS standard and should be reconciled to current IFRS 15.B-21 guidance.

Test plan summary

Eight test procedures have been authored covering all generated risks. Sampling guidance follows the entity's prior-year audit programme where directly applicable. Recommended frequency is documented per procedure.

Reviewer notes

Draft notes are editable. Update this narrative to reflect reviewer judgement and add any matters arising from the engagement letter that fall outside Lumind's automated synthesis.